Back to search

University of British Columbia

Role of receptor tyrosine kinase like orphan receptor 2 in treatment-resistant prostate cancer

Abstract

dc:description

Potent androgen receptor pathway inhibitors such as Enzalutamide (ENZ) and Abiraterone (Abi) have become the gold standard for patients with castration resistant prostate cancer (CRPC). However, treatment resistance is inevitable and all patients eventually become insensitive to these treatments. To investigate the molecular mechanism of treatment resistance in prostate cancer, our laboratory has engineered ENZ-resistant (ENZR) CRPC cell lines, which mirror clinical observations, through serial passaging of LNCaP xenografts under ENZ. Using our RNA sequencing data, we found Receptor tyrosine kinase like orphan receptor 2 (ROR2) as one of the most upregulated receptor tyrosine kinases (RTKs) in both our in vitro cell lines and patients. The oncogenic roles of ROR2 have been elucidated in various cancers, including prostate cancer. However, the role of ROR2 in context of treatment resistance in prostate cancer is still unknown. For the first time, we generated a novel ROR2 gene signature to provide insights on its role in treatment-resistant prostate cancer using RNA sequencing data of in vitro models and patients. We successfully validated the legitimacy of ROR2 gene signature in various models. Correlation studies revealed that ROR2 activity may be ligand-independent. Further examination of ROR2 gene signature revealed that ROR2 upregulates CD274 (known as programmed death-ligand 1; PD-L1) in treatment-resistant setting. Various computational studies and in vitro experiments supported and validated the novel ROR2-CD274 axis. Together, our data reveal a novel discovery of ROR2-CD274 axis in treatment-resistant prostate cancer.

Degree

thesis:*
Name thesis:degree_name
Master of Science - MSc
Level thesis:degree_level
master's
Discipline thesis:degree_discipline
Experimental Medicine
Grantor dc:publisher
University of British Columbia
Year dc:date
2020

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Ahn, Chihwan (Paul)

Rights

dc:rights
Statement dc:rights
  • Attribution-NonCommercial-NoDerivatives 4.0 International
Language dc:language
eng

Identifiers

dc:identifier.*
Handle dc:identifier
http://hdl.handle.net/2429/74182

Chain of custody

source
Harvested from
University of British Columbia
Base URL
circle.library.ubc.ca/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
related terms
citation

Ahn, Chihwan (Paul). Role of receptor tyrosine kinase like orphan receptor 2 in treatment-resistant prostate cancer. master's thesis, University of British Columbia, 2020. http://hdl.handle.net/2429/74182